Ministry of Health, Labour and Welfare (Japan)

organization

Last mentioned: Mar 6, 2026

Timeline

  1. Regulatory Approval

    Japan's Ministry of Health officially approves the therapy for clinical use.

  2. Data Submission

    Sumitomo Pharma submits trial data to Japan's PMDA for regulatory review.

  3. Clinical Trial Launch

    Kyoto University begins the first human clinical trial for iPS-derived Parkinson's treatment.

  4. Nobel Prize Awarded

    Shinya Yamanaka wins the Nobel Prize for the discovery of iPS cells.

Stories mentioning Ministry of Health, Labour and Welfare (Japan) 1

regulation Very Bullish

Japan Approves World-First iPS Stem-Cell Therapy for Parkinson’s Disease

Japan's Ministry of Health has granted regulatory approval for a groundbreaking stem-cell treatment for Parkinson's disease, marking the first time induced pluripotent stem cells (iPS) have been cleared for clinical use. The therapy, developed by Kyoto University and Sumitomo Pharma, aims to restore dopamine-producing neurons in the brain.

3 sources